Skip to main content

Characterization of EBV-Infected Epithelial Cell Lines from Gastric Cancer-Bearing Tissues

  • Chapter
Epstein-Barr Virus and Human Cancer

Abstract

The long-term goal of our study is to explore how Epstein-Barr virus (EBV) associates with the pathogenesis of gastric carcinoma. The first goal is to establish EBV-positive epithelial cell lines from EBV-infected gastric carcinoma tissues and to characterize the cell lines and EBV infection in the cells. EBV, a ubiquitous human herpesvirus with oncogenic potential, is predominantly associated with the infection of two target tissues in vivo: (1) B lymphocytes, where the infection is largely nonproductive, and (2) the epithelium, in which virus replication occurs (Rickinson and Kieff 1996). Both target tissues are susceptible to EBV-associated malignant change, leading to tumors of B-cell origin, such as Burkitt’s lym-phoma, or of epithelial-cell origin, such as nasopharyngeal carcinoma (NPC) (Pathmanathan et al. 1995). Recently, EBV has also emerged as an etiologic agent implicated in gastric carcinoma (Min et al. 1991; Shibata et al. 1991; Shibata and Weiss 1992; Tokunaga et al. 1993a,b; Fukayama et al. 1994; Imai et al. 1994; Ohfuji et al. 1996; Iwasaki et al. 1998). EBV has been found in most cases of rare gastric lymphoepithelioma-like carcinomas (Min et al. 1991; Shibata et al. 1991; Ohfuji et al. 1996) and a small but significant proportion of common gastric adenocarcinomas (Shibata and Weiss 1992; Tokunaga et al. 1993a,b). EBV infection was found in approximately 7% of Japanese gastric carcinomas (Tokunaga et al. 1993a,b; Fukayama et al. 1994; Imai et al. 1994). The world distribution of gastric carcinomas with EBV infection is shown from 4% to 18% of total gastric carcinoma in different countries (Tashiro et al. 1998)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA (1995) Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 69:7001–7005

    PubMed  CAS  Google Scholar 

  • Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851

    PubMed  CAS  Google Scholar 

  • Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whiteney BM, Lee JCK (1999) Nasopharyngeal carcinoma cell line (C666-l) consistently harbouring Epstein-Barr virus. Int J Cancer 83:121–126

    Article  PubMed  CAS  Google Scholar 

  • Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A (1986) Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. Embo J 5:3243–3249

    PubMed  CAS  Google Scholar 

  • Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085–4089

    Article  PubMed  CAS  Google Scholar 

  • Croen KD (1993) Evidence for antiviral effect of nitric oxide: Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91:2446–2452

    Article  PubMed  CAS  Google Scholar 

  • Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K (1994) Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71:73–81

    PubMed  CAS  Google Scholar 

  • Gao X, Tajima M, Sairenji T (1999) Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. Virology 258:375–381

    Article  PubMed  CAS  Google Scholar 

  • Gilad E, Zingarelli B, Salzman AL, Szabo C (1997) Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol 29:2585–2597

    Article  PubMed  CAS  Google Scholar 

  • Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP (1989) Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86:9524–9528

    Article  PubMed  CAS  Google Scholar 

  • Harris N, Buller RM, Karupiah G (1995) Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 69:910–915

    PubMed  CAS  Google Scholar 

  • zur Hausen H, O’Neill FJ, Freese UK, Hecker E (1978) Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272:373–375

    Article  PubMed  Google Scholar 

  • Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T (2000) Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes and Infection 2:115–120

    Article  PubMed  CAS  Google Scholar 

  • Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131–9135

    Article  PubMed  CAS  Google Scholar 

  • Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371–4378

    PubMed  CAS  Google Scholar 

  • Iwasaki Y, Chong JM, Hayashi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M (1998) Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321–8326

    PubMed  CAS  Google Scholar 

  • Kanamori M, Tajima M, Satoh Y, Hoshikawa Y, Miyazawa Y, Okinaga K, Kurata T, Sairenji T (2000) Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji. Virus Genes 20:117–125

    Article  PubMed  CAS  Google Scholar 

  • Katano H, Morishita Y, Cui LX, Watanabe T, Hirai K, Mori S (1996) Expression of latent membrane protein 1 in clinically isolated cases and animal models of AIDS-associated non-Hodgkin’s lymphomas. Pathol Int 46:568–574

    Article  PubMed  CAS  Google Scholar 

  • Kawanishi M (1995) Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV. Intervirology 38:206–213

    PubMed  CAS  Google Scholar 

  • Klein G (1998) EBV and B cell lymphomas. In: Medveczky PG, Friedman H, Bendinelli M (eds) Herpesvirus and immunity. Plenum Press, New York and London

    Google Scholar 

  • Kunimoto M, Tamura S, Tabata T, Yoshie O (1992) One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol 73:455–461

    Article  PubMed  CAS  Google Scholar 

  • Luka J, Kallin B, Klein G (1979) Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231

    Article  PubMed  CAS  Google Scholar 

  • MacPherson I, Montagnier L (1964) Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23:291–297

    Article  PubMed  CAS  Google Scholar 

  • Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137–1146

    Article  PubMed  CAS  Google Scholar 

  • Min KW, Holmquist S, Peiper SC, O’Leary TJ (1991) Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach: Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 96: 219–227

    PubMed  CAS  Google Scholar 

  • Murakami M, Hoshikawa Y, Satoh Y, Ito H, Tajima M, Okinaga K, Miyazawa Y, Kurata T, Sairenji T (2000) Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse. Virology 277:20–26

    Article  PubMed  CAS  Google Scholar 

  • Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051–3064

    PubMed  CAS  Google Scholar 

  • Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K (1999) Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 73:1286–1292

    PubMed  CAS  Google Scholar 

  • Ohfuji S, Osaki M, Tsujitani S, Ikeguchi M, Sairenji T, Ito H (1996) Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int J Cancer 68:710–715

    Article  PubMed  CAS  Google Scholar 

  • Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698

    Article  PubMed  CAS  Google Scholar 

  • Pope M, Marsden PA, Cole E, Sloan S, Fung LS, Ning Q, Ding JW, Leibowiz JL, Phillips MJ, Levey GA (1998) Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J Virol 72:7084–7090

    PubMed  CAS  Google Scholar 

  • Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889

    Article  PubMed  CAS  Google Scholar 

  • Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al. (eds) Fields Virology, 3rd edn. Raven Press, New York

    Google Scholar 

  • Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147–158

    Article  PubMed  CAS  Google Scholar 

  • Sairenji T, Hinuma Y (1980) Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int J Cancer 26:337–342

    Article  PubMed  CAS  Google Scholar 

  • Sekiguchi M, Suzuki T (1994) Gastric tumor cell lines. In: Hay RJ, Park J-G, Gazdar AF (eds) Atlas of human tumor cell lines. Academic Press, London

    Google Scholar 

  • Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469–474

    PubMed  CAS  Google Scholar 

  • Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769–774

    PubMed  CAS  Google Scholar 

  • Shimizu N, Tanabe Tochikura A, Kuroiwa Y, Takada K (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt’s lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069–6073

    PubMed  CAS  Google Scholar 

  • Tajima M, Komuro M, Okinaga K (1998) Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J Cancer Res 89:262–268

    Article  PubMed  CAS  Google Scholar 

  • Takada K, Shimizu N, Sakuma S, Ono Y (1986) Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57:1016–1022

    PubMed  CAS  Google Scholar 

  • Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T, Sairenji T (1998) Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Virology 247:152–159

    Article  PubMed  CAS  Google Scholar 

  • Takimoto T, Ogura H, Sato H, Umeda R, Hatano M (1985) Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J Natl Cancer Inst 74:57–60

    PubMed  CAS  Google Scholar 

  • Tashiro Y, Arikawa J, Itoh T, Tokunaga M (1998) Clinico-pathological findings of Epstein-Barr virus-related gastric cancer. In: Osato T, Takada K, Tokunaga M (eds) Epstein-Barr virus and human cancer. Monograph on cancer research No. 45, Japan Scientific Society Press, Karger, Basel Freiburg Paris London New York New Delhi Bangkok Singapore Tokyo Sydney

    Google Scholar 

  • Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E (1993a) Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250–1254

    PubMed  CAS  Google Scholar 

  • Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, Kaneko K, Naoe S, Ito M,Okamura A, Shimada A, Sato E, Land CE (1993b) Epstein-Barr virus related gastric cancer in Japan:a molecular patho-epidemiological study. Acta Pathol Jpn 43:574–581

    PubMed  CAS  Google Scholar 

  • Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, Glaser R (1990) Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 45:83–89

    Article  PubMed  CAS  Google Scholar 

  • Yoshiyama H, Imai S, Shimizu N, Takada K (1997) Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD2l. J Virol 71:5688–5691

    PubMed  CAS  Google Scholar 

  • Zalani S, Holley Guthrie E, Kenney S (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA 93:9194–9199

    Article  PubMed  CAS  Google Scholar 

  • Zhang HY, Yao K, Zhu HC, Glaser R (1990) Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Int J Cancer 46:944–949

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sairenji, T. et al. (2001). Characterization of EBV-Infected Epithelial Cell Lines from Gastric Cancer-Bearing Tissues. In: Takada, K. (eds) Epstein-Barr Virus and Human Cancer. Current Topics in Microbiology and Immunology, vol 258. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56515-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56515-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62568-8

  • Online ISBN: 978-3-642-56515-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics